Clinical Trial Update: Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam [Phase 1]

View source ↗

Summary

Phase 1 clinical study in healthy volunteers to evaluate the neurocognitive effects of Brivaracetam, an antiepileptic drug, sponsored by UCB Pharma; the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 1 | Status: COMPLETED